Assessing the efficacy, safety and utility of 6-month day-and-night automated closed-loop insulin delivery under free-living conditions compared with insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, multicentre, multin-MedSci.cn

Assessing the efficacy, safety and utility of 6-month day-and-night automated closed-loop insulin delivery under free-living conditions compared with insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, multicentre, multin

Musolino, G; Allen, JM; Hartnell, S; Wilinska, ME; Tauschmann, M; Boughton, C; Campbell, F; Denvir, L; Trevelyan, N; Wadwa, P; DiMeglio, L; Buckingham, BA; Weinzimer, S; Acerini, CL; Hood, K; Fox, S; Kollman, C; Sibayan, J; Borgman, S; Cheng, PY; Hov

Hovorka, R (reprint author), Univ Cambridge, Wellcome Trust MRC Inst Metab Sci, Cambridge, England.; Hovorka, R (reprint author), Univ Cambridge, Dept Paediat, Cambridge, England.

BMJ OPEN, 2019; 9 (6):

Abstract

Introduction Closed-loop systems titrate insulin based on sensor glucose levels, providing novel means to reduce the risk of hypoglycaemia while impro......

Full Text Link

Links

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Assessing the efficacy, safety and utility of 6-month day-and-night automated closed-loop insulin delivery under free-living conditions compared with insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, multicentre, multin

科室

工具

服务